Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Most linked-to pages

From GxPlex

Jump to: navigation, search

Showing below up to 50 results in range #501 to #550.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Reference:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 III - IV. (7 links)
  2. Reference:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 III B. 3. (7 links)
  3. Reference:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 VI C. (7 links)
  4. Reference:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 VI D. (7 links)
  5. Reference:USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. A. (7 links)
  6. Reference:USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 III. (7 links)
  7. Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 1.3 (7 links)
  8. Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 1.4 (7 links)
  9. Reference:WHO WHO - Guidance for best practices for clinical trials 2024 2.1.3 (7 links)
  10. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 1.4 (7 links)
  11. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 10.4 (7 links)
  12. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.10 (7 links)
  13. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.16 (7 links)
  14. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.4 - immediate hazard (7 links)
  15. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 5.13 (7 links)
  16. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 5.6 (7 links)
  17. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 6 (7 links)
  18. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 6.2 (7 links)
  19. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 7.2 - Investigator (7 links)
  20. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 7.2 - Sponsor (7 links)
  21. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - monitor (7 links)
  22. Reference:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 Page 60-61 (7 links)
  23. Reference:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 WHO Principles of GCP (7 links)
  24. Glossary:TAG-00035-Man-odu (7 links)
  25. Glossary:TAG-00147-Ser-inD (7 links)
  26. Glossary:TAG-00151-Sta-rat (7 links)
  27. Glossary:TAG-00193-Hea-Ang (7 links)
  28. Glossary:TAG-00204-Cli-tbe (7 links)
  29. Glossary:TAG-00269-Wit-der (7 links)
  30. Glossary:TAG-00322-Fed-imi (7 links)
  31. Glossary:TAG-00324-Med-Age (7 links)
  32. Document:CIOMS CIOMS - International Ethical Guidelines for Biomedical Research Involving Human Subjects 2016 (6 links)
  33. Document:EU ; GBR MDCG 2020-10/1 - Safety reporting in clinical investigations of medical devices 2020 (6 links)
  34. Document:EU Directive 2001/83/EC - Community code relating to medicinal products for human use 20-Jun-12 (6 links)
  35. Document:USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 (6 links)
  36. Reference:AUT BASG - FAQ 11-Feb-2025 Änderung am Personal (6 links)
  37. Reference:AUT FAQ - COVID-19 Studien 15-Mar-2021 - (6 links)
  38. Reference:AUT MPG – Medizinproduktegesetz 26-May-2022 § 22 (6 links)
  39. Reference:AUT Question - BASG 11-Feb-2025 - (6 links)
  40. Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 2 Absatz 3a–4 (6 links)
  41. Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40 (6 links)
  42. Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40 Absatz 2 (6 links)
  43. Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b Absatz 2 (6 links)
  44. Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b Absatz 3 (6 links)
  45. Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b Absatz 4 (6 links)
  46. Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b Absatz 6-001 (6 links)
  47. Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40c-002 (6 links)
  48. Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40d-001 (6 links)
  49. Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40d-002 (6 links)
  50. Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40d-003 (6 links)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://gxplex.org/index.php?title=Special:MostLinkedPages"